Terms: = Endocrine gland cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Prognosis
4 results:
1. Predicting positive peritoneal cytology in pancreatic cancer.
O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
[TBL] [Abstract] [Full Text] [Related]
2. Increased levels of xpa might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract] [Full Text] [Related]
3.
Yoshii Y; Matsumoto H; Yoshimoto M; Oe Y; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
J Nucl Med; 2019 Oct; 60(10):1437-1443. PubMed ID: 30850497
[TBL] [Abstract] [Full Text] [Related]
4. Association between ERCC1 and xpa expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
[TBL] [Abstract] [Full Text] [Related]
